Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City. uri icon

Overview

publication date

  • May 20, 2022

Research

keywords

  • COVID-19
  • Rheumatology

Identity

PubMed Central ID

  • PMC9122542

Digital Object Identifier (DOI)

  • 10.1007/s10067-022-06203-1

PubMed ID

  • 35596096